A detailed history of Smartleaf Asset Management LLC transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Smartleaf Asset Management LLC holds 247 shares of HRMY stock, worth $8,412. This represents 0.0% of its overall portfolio holdings.

Number of Shares
247
Previous 74 233.78%
Holding current value
$8,412
Previous $2.33 Million 314.98%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$30.0 - $39.95 $5,190 - $6,911
173 Added 233.78%
247 $9.67 Million
Q2 2024

Aug 13, 2024

BUY
$28.81 - $33.01 $1,728 - $1,980
60 Added 428.57%
74 $2.33 Million
Q1 2024

Oct 07, 2024

SELL
$29.93 - $35.06 $1,795 - $2,103
-60 Reduced 81.08%
14 $469,000
Q1 2024

May 02, 2024

BUY
$29.93 - $35.06 $419 - $490
14 New
14 $466,000

Others Institutions Holding HRMY

About Harmony Biosciences Holdings, Inc.


  • Ticker HRMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,161,400
  • Market Cap $2.02B
  • Description
  • Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...
More about HRMY
Track This Portfolio

Track Smartleaf Asset Management LLC Portfolio

Follow Smartleaf Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Smartleaf Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Smartleaf Asset Management LLC with notifications on news.